The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$6.51

Today's change0.00 0.00%
Updated December 8 3:36 PM EST. Delayed by at least 15 minutes.
 

Aralez Pharmaceuticals Inc

TSX: ARZ
Delayed quote

$6.51

Today's change0.00 0.00%
Updated December 8 3:36 PM EST. Delayed by at least 15 minutes.

Aralez Pharmaceuticals Inc closed at $6.51.

Shares have lost 4.12% over the last five days, but have gained 389.47% over the last year to date. This security has outperformed the S&P TSX by 371.11% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$2.17
Updated December 8 3:36 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-211.76%

Aralez Pharmaceuticals Inc has a net profit margin of -211.76%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.38%Sector:Industry:

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue141386
Total other revenue--------
Total revenue141386
Gross profit1096--
Total cost of revenue333--
Total operating expense33304620
Selling / general / administrative25233717
Research & development2143
Depreciation / amortization221--
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-20-17-38-14
Interest income (expense), net non-operating0-10--
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-18-33-14
Income after tax-21-17-34-13
Income tax, total0-11-1
Net income-21-17-34-13
Total adjustments to net income--------
Net income before extra. items-21-17-34-13
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-21-17-34-13
Inc. avail. to common incl. extra. items-21-17-34-13
Diluted net income-21-17-34-13
Dilution adjustment--------
Diluted weighted average shares65645233
Diluted EPS excluding extraordinary itemsvalue per share-0.32-0.27-0.65-0.40
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.32-0.27-0.65-0.40